Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Schindler

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Molecular & Cellular Proteomics : MCP|December 2, 2005
Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometryDébora Bonenfant, Michèle Coulot, Harry Towbin, et al.
Proteomics|November 8, 2002
Post-translational modification detection using metastable ions in reflector matrix-assisted laser desorption/ionization-time of flight mass spectrometryUrs Wirth, Dieter Müller, Patrick Schindler, et al.
Pharmaceutics|March 28, 2024
Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68</sup>Ga-Labeled RadiopharmaceuticalsRahel H Wallimann, Heloïse Hensinger, Cristina Müller, et al.
Expert Review of Clinical Immunology|November 15, 2022
Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current reviewPatrick Schindler, Orhan Aktas, Marius Ringelstein, et al.
Molecular & Cellular Proteomics : MCP|July 24, 2007
Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometryDébora Bonenfant, Harry Towbin, Michèle Coulot, et al.
Multiple Sclerosis and Related Disorders|June 20, 2024
Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort studyPatrick Schindler, Judith Bellmann-Strobl, Jens Kuhle, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 21, 2022
Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD)Darius Mewes, Joseph Kuchling, Patrick Schindler, et al.
Frontiers in Neurology|February 12, 2024
Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGADSusanna Asseyer, Ofir Zmira, Laura Busse, et al.
Journal of Chromatography. A|October 4, 2015
Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodiesFabian Holenstein, Christer Eriksson, Ioana Erlandsson, et al.
Molecular Pharmaceutics|February 24, 2023
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of RadiopharmaceuticalsRahel H Wallimann, Patrick Schindler, Heloïse Hensinger, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Molecular & Cellular Proteomics : MCP|December 2, 2005
Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometryDébora Bonenfant, Michèle Coulot, Harry Towbin, et al.
Proteomics|November 8, 2002
Post-translational modification detection using metastable ions in reflector matrix-assisted laser desorption/ionization-time of flight mass spectrometryUrs Wirth, Dieter Müller, Patrick Schindler, et al.
Pharmaceutics|March 28, 2024
Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68</sup>Ga-Labeled RadiopharmaceuticalsRahel H Wallimann, Heloïse Hensinger, Cristina Müller, et al.
Expert Review of Clinical Immunology|November 15, 2022
Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current reviewPatrick Schindler, Orhan Aktas, Marius Ringelstein, et al.
Molecular & Cellular Proteomics : MCP|July 24, 2007
Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometryDébora Bonenfant, Harry Towbin, Michèle Coulot, et al.
Multiple Sclerosis and Related Disorders|June 20, 2024
Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort studyPatrick Schindler, Judith Bellmann-Strobl, Jens Kuhle, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 21, 2022
Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD)Darius Mewes, Joseph Kuchling, Patrick Schindler, et al.
Frontiers in Neurology|February 12, 2024
Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGADSusanna Asseyer, Ofir Zmira, Laura Busse, et al.
Journal of Chromatography. A|October 4, 2015
Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodiesFabian Holenstein, Christer Eriksson, Ioana Erlandsson, et al.
Molecular Pharmaceutics|February 24, 2023
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of RadiopharmaceuticalsRahel H Wallimann, Patrick Schindler, Heloïse Hensinger, et al.
Pageof 6